Copper (Cu), a crucial trace element in physiological processes, has garnered significant
interest for its involvement in cancer progression and potential therapeutic applications. The …

As an inherent metal ion, copper has been the subject of investigation for developing a
novel antitumoral compound that exhibits fewer adverse effects. Copper serves as a cofactor …

For decades, tamoxifen-based hormone therapy has effectively addressed oestrogen
receptor positive (ER+) luminal A breast cancer. Nonetheless, the emergence of tamoxifen …

The interactions with calf thymus DNA (CT-DNA) of three Schiff bases formed by the
condensation of hesperetin with benzohydrazide (HHSB or L1H3), isoniazid (HIN or L2H3) …

Terpyridine‐based complexes with group 11 metals emerge as potent metallodrugs in
cancer therapy. This comprehensive review focuses on the current landscape of anticancer …

Copper (II)-terpyridine complexes are endowed with the ability to generate reactive oxygen
species (ROS) and induce cancer cell death. Here we report the synthesis, characterisation …

Eight 2, 2′: 6′, 2 ″-terpyridines, substituted at the 4′-position with aromatic groups
featuring variations in π-conjugation, ring size, heteroatoms, and methoxy groups, were …

Reactive oxygen species (ROS) generation with subsequent DNA damage is one of the
principle mechanisms of action assigned to copper-based anticancer complexes. The …

Cancer is considered as the biggest medicinal challenge worldwide. During a typical
treatment, the tumorous tissue is removed in a surgical procedure and the patient further …

Cu (II) complexes of positively charged amino acids L–Lysine and L‐Arginine appended to
an anthracene unit and phenanthroline bases, namely [Cu (Anth‐Lys)(L)(ClO4)](1, 2) and …